Noked Capital’s Amgen AMGN Stock Holding History

Noked Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,500	Closed	-$276K	–	41
2019 Q2	$276K	Buy	+1,500	New	+$269K	0.34%	56

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Noked Capital's AMGN Position: Q3 2019 in Review

Noked Capital sold out of Amgen (AMGN) in Q3 2019, closing a stake of 1,500 shares — an estimated $276K sold.

Noked Capital first reported a position in AMGN in Q2 2019 and held it in 1 quarter. The position peaked at $276K in Q2 2019. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

Noked Capital reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
Noked Capital sold 1,500 Amgen shares in Q3 2019, an estimated $276K.
Noked Capital first reported a position in Amgen in Q2 2019 and held it in 1 quarter.
Noked Capital's Amgen position peaked at $276K in Q2 2019.
1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Noked Capital's 13F filing for Q3 2019, filed 14 Nov 2019.